Evaluation of the Subjectively Perceived Pelvic Floor Function in Patients With Gynecological Tumors and Breast Cancer Under Systemic Tumor Therapy Using a Validated Questionnaire
Launched by ST. JOSEFS-HOSPITAL WIESBADEN GMBH · Dec 3, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how cancer treatment affects the pelvic floor function in patients with gynecological tumors and breast cancer. The pelvic floor is a group of muscles that supports the bladder, bowel, and sexual organs. Many patients undergoing treatment for these types of cancer experience problems in these areas, which can significantly affect their quality of life. The researchers will use special questionnaires to gather information about these issues from participants, aiming to better understand the challenges they face and find ways to help manage or prevent these symptoms.
If you are a patient receiving treatment for breast cancer or a gynecological cancer, you may be eligible to participate in this study. There are no specific age restrictions, and both men and women can take part. Participants will be asked to fill out questionnaires about their bladder, bowel, and sexual health during the trial. This information will help researchers identify how treatment impacts pelvic floor function and may lead to improved care for patients in the future. The study is currently recruiting participants, and your involvement could contribute to meaningful advancements in understanding these issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Breastcancer under tumor therapy
- • Gynecological carcinoma under tumor therapy
- Exclusion Criteria:
- • none
About St. Josefs Hospital Wiesbaden Gmbh
St. Josefs-Hospital Wiesbaden GmbH is a leading healthcare institution dedicated to delivering high-quality medical care and advancing clinical research. With a commitment to patient-centered practices, the hospital integrates innovative treatment methodologies and state-of-the-art technology to enhance clinical outcomes. As a sponsor of clinical trials, St. Josefs-Hospital Wiesbaden GmbH emphasizes collaboration with academic and industry partners to contribute to the development of groundbreaking therapies, ensuring adherence to rigorous ethical standards and regulatory compliance. Their multidisciplinary approach fosters an environment of excellence in research, ultimately aiming to improve patient health and well-being.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wiesbaden, , Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials